The long-term objective of this proposal is to elucidate the mechanism by which BRCAI suppresses breast and ovarian cancers. Although BRCAI has been implicated in transcriptional regulation and DNA repair, its exact function in these processes remains to be understood. Even less is known concerning the tissue-specificity of BRCA 1-dependent cancer risks. Recent work in this laboratory has led to the discovery of a novel cell-type-dependent trans-activation domain in BRCA1. Furthermore, this domain specifically interacts with JunB and JunD, two AP-I proteins that are involved in negative regulation of cell proliferation. Therefore, it is hypothesized that BRCA1, by targeting specific members of the AP-1 family, modulates their functions in transcriptional regulation and cell cycle control. Disruption of the BRCA 1-Jun interaction may contribute to an elevated tissue-specific cancer risk.
The specific aims of the proposal are: 1) To determine how BRCA1 selectively binds to specific members of the AP-l family. The amino acid residues responsible for the BRCA 1-Jun interaction will be identified. The relative binding affinity of BRCAI for the different AP-1 proteins will be determined. 2) To study the functional cooperation of BRCA 1 and the Jun proteins in transcriptional regulation. Primary efforts will be focused on the role of the BRCA 1-Jun complex in the transcriptional regulation of the downstream target genes-that are involved in cell cycle control, such as cyclin Dl, p16, and p21. 3) To assess the role of the BRCAI-Jun interaction in the control of cell proliferation and stress response in breast and ovary cells. The BRCA 1-Jun complex formation during the normal cell cycle and stress response will be investigated. Various cell biological assays will be utilized to determine the cooperation between BRCAI and the Jun proteins in cell cycle control and anti-oncogenesis. The proposed study promises to shed new insights into the functional connection between BRCAI and the Jun proteins. It will also provide potential therapeutic targets for correcting the defects caused by BRCAI mutations.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research Project (R01)
Project #
5R01CA093506-02
Application #
6620400
Study Section
Special Emphasis Panel (ZRG1-PTHC (01))
Program Officer
Mietz, Judy
Project Start
2002-07-01
Project End
2006-06-30
Budget Start
2003-07-01
Budget End
2004-06-30
Support Year
2
Fiscal Year
2003
Total Cost
$287,760
Indirect Cost
Name
University of Virginia
Department
Biochemistry
Type
Schools of Medicine
DUNS #
065391526
City
Charlottesville
State
VA
Country
United States
Zip Code
22904
Pan, Haihui; Qin, Kunhua; Guo, Zhanyong et al. (2014) Negative elongation factor controls energy homeostasis in cardiomyocytes. Cell Rep 7:79-85
Chiang, Huai-Chin; Nair, Sreejith J; Yeh, I-Tien et al. (2012) Association of radiotherapy with preferential depletion of luminal epithelial cells in a BRCA1 mutation carrier. Exp Hematol Oncol 1:31
Ghosh, Sagar; Kang, Tao; Wang, Howard et al. (2011) Mechanical phenotype is important for stromal aromatase expression. Steroids 76:797-801
Vachon, Celine M; Sasano, Hironobu; Ghosh, Karthik et al. (2011) Aromatase immunoreactivity is increased in mammographically dense regions of the breast. Breast Cancer Res Treat 125:243-52
Ghosh, Sagar; Dean, Angela; Walter, Marc et al. (2010) Cell density-dependent transcriptional activation of endocrine-related genes in human adipose tissue-derived stem cells. Exp Cell Res 316:2087-98
Ghosh, Sagar; Hu, Yanfen; Li, Rong (2010) Cell density is a critical determinant of aromatase expression in adipose stromal cells. J Steroid Biochem Mol Biol 118:231-6
Walter, M; Liang, S; Ghosh, S et al. (2009) Interleukin 6 secreted from adipose stromal cells promotes migration and invasion of breast cancer cells. Oncogene 28:2745-55
Ghosh, Sagar; Choudary, Ahsan; Ghosh, Sangeeta et al. (2009) IKKbeta mediates cell shape-induced aromatase expression and estrogen biosynthesis in adipose stromal cells. Mol Endocrinol 23:662-70
Wang, Hanzhou; Li, Rong; Hu, Yanfen (2009) The alternative noncoding exons 1 of aromatase (Cyp19) gene modulate gene expression in a posttranscriptional manner. Endocrinology 150:3301-7
Wen, J; Li, R; Lu, Y et al. (2009) Decreased BRCA1 confers tamoxifen resistance in breast cancer cells by altering estrogen receptor-coregulator interactions. Oncogene 28:575-86

Showing the most recent 10 out of 17 publications